FATE Fate Therapeutics Inc Yakuniy foyda

Fate Therapeutics (FATE) korporativ emblemasi va logotipi

Fate Therapeutics, Inc. (FATE) qiymati o'smalarga qarshi kurashishda stam hujayralaridan foydalanishning innovatsion uslubiga asoslangan bo'lib, marja samaradorligi ishlanmalar natijalariga bog'liqdir. Ushbu yuqori texnologik sektor iqtisodiy sikllarga bog'liq emas, chunki bu yerdagi muvaffaqiyat sherikliklar va klinik sinovlarga bog'liq. GURU.Markets platformasidagi joriy bozor qiymatining ushbu kunlik narxlar grafigi -0.13 darajasidagi foydani ko'rsatib, kompaniyaning onkoterapiya sohasidagi maqomini tasdiqlaydi.

FATE (Fate Therapeutics, Inc.) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha
Fate Therapeutics Inc ishlab chiqargan mahsulot

Fate Therapeutics, Inc. (FATE) uchun kompaniyaning tijorat natijasi onkologik innovatsiyalarning monetizatsiya dinamikasini aks ettiradi. Ushbu ko'rsatkich kunlik sof foydani aniqlaydi va joriy pul oqimining ob'ektiv o'lchovi vazifasini bajaradi. Hisob-kitoblar har bir savdo kunining operatsion natijalariga asoslangan bo'lib, hisobot vaqtidagi kechikishlarni bartaraf etadi. AQSh dagi barqaror operatsion muhit tashqi xavflarni minimallashtirib, ushbu ma'lumotlarning ishonchliligini oshiradi. Foydaning aniq monitoringi cho'qqi nuqtalarda sotib olayotganda kapitalning muzlatilishini oldini olishga yordam beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi BeiGene Oncology (ONC)|Kompaniyaning sof foydasi Halozyme Therapeutics|RVMD: Yakuniy foyda|Sof daromad AAPG (Ascentage Pharma)|CGON (CG Oncology Inc) - Yakuniy foyda|Sof foyda URGN (UroGen)|BCAX - Sof daromad|PSNL: Sof daromad|ERAS - Sof foyda|Delcath Systems (DCTH) - Kompaniyaning sof foydasi|Y-mAbs Therapeutics Inc - Yakuniy foyda|AURA (Aura Bio) - Sof foyda|Kompaniyaning sof daromadi Candel CADL|Sof foyda ARAY|SLS: Soliqdan keyingi foyda|Sof foyda ACTU (Actuate Therapeutics)|Sof foyda Citius Oncology Inc. CTOR|HURA: Sof daromad|Protara Tx - Soliqlar to‘langandan keyingi foyda|WHWK: Sof foyda|Kompaniyaning sof daromadi TScan Therapeutics, Inc. (TCRX)|Sof daromad CSBR|XBIT: Yakuniy foyda|Sof daromad CVM (CEL-SCI Corporation)|Soliqlar to‘langandan keyingi foyda OSTX|Sof foyda RADX (Radiopharm Theranostics Limited)|Yakuniy foyda ARTV|Adlai Nortye Limited - Sof foyda|Kompaniyaning sof daromadi Veru Inc|Tempest Tx (TPST) - Kompaniyaning sof foydasi|Xilio Therapeutics - Yakuniy foyda|RENB (Renovaro Biosciences) - Sof foyda|Sof foyda Mural Bio|Kompaniyaning sof foydasi Kairos Pharma Ltd (KAPA)|OKUR: Soliqdan keyingi foyda|Sof foyda GDTC (CytoMed Therapeutics Limited)|Curis Inc. (CRIS) - Kompaniyaning sof daromadi|APLM: Sof daromad|THAR - Sof foyda|ADVB (advanbiomed.com) - Sof daromad|GNPX: Soliqlar to‘langandan keyingi foyda|CLDI (Calidi Biotherapeutics Inc.) - Sof foyda|Sunshine Biopharma Inc. (SBFM) - Sof moliyaviy natija|Sof foyda XBIO|Sof daromad salariuspharma.com SLRX|Kompaniyaning sof foydasi Purple Biotech Ltd. PPBT|Sof moliyaviy natija American Oncology Network Inc (AONC)|BGNE: Sof daromad|Yakuniy foyda CKPT (Checkpoint Therapeutics Inc)|ELEV: Sof foyda|ICAD - Sof moliyaviy natija|Kompaniyaning sof foydasi Ikena Oncology Inc.|Kompaniya foydasi NTBL (Notable Labs Ltd)|Sof foyda VIRX|Sof daromad MorphoSys Corporation MOR|NAYA Biosciences - Sof daromad|Sof moliyaviy natija ascentage.com (AAPGV)